Shanghai Fosun Pharmaceutical Group Co Ltd Free Cash Flow Generation Index
Shanghai Fosun Pharmaceutical Group Co Ltd free cash flow generation index. Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Free Cash Flow Generation Index of 0.47x as of December 2025. Free cash flow of CN¥1.12 Billion represents 0% of operating cash flow (CN¥2.40 Billion). Check asset resilience ratio of Shanghai Fosun Pharmaceutical Group Co L to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Free cash flow generation index of Shanghai Fosun Pharmaceutical Group Co Ltd from 1998 to 2025. Historical FCF Generation Index trend for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Explore reinvestment intensity of Shanghai Fosun Pharmaceutical Group Co L to see what proportion of operating cash flow is directed to capital expenditures.
Shanghai Fosun Pharmaceutical Group Co Ltd Free Cash Flow Generation Index by Year (1998–2025)
Shanghai Fosun Pharmaceutical Group Co Ltd free cash flow generation index by year from 1998 to 2025. Year-by-year Free Cash Flow Generation Index for Shanghai Fosun Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 600196 cash flow metrics.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | CN¥1.56 Billion | CN¥6.01 Billion | CN¥4.45 Billion | ▲ +1637.7% |
| 2024 | 0.01x | CN¥66.79 Million | CN¥4.48 Billion | CN¥4.41 Billion | ▲ +103.4% |
| 2023 | -0.44x | CN¥-1.92 Billion | CN¥4.36 Billion | CN¥5.34 Billion | ▼ -11.2% |
| 2022 | -0.40x | CN¥-1.67 Billion | CN¥4.22 Billion | CN¥5.89 Billion | ▼ -52.8% |
| 2021 | -0.26x | CN¥-1.02 Billion | CN¥3.95 Billion | CN¥4.97 Billion | ▲ +64.0% |
| 2020 | -0.72x | CN¥-1.86 Billion | CN¥2.58 Billion | CN¥4.44 Billion | ▼ -213.7% |
| 2019 | -0.23x | CN¥-739.65 Million | CN¥3.22 Billion | CN¥3.96 Billion | ▼ -201.2% |
| 2018 | -0.08x | CN¥-224.81 Million | CN¥2.95 Billion | CN¥3.17 Billion | ▼ -148.0% |
| 2017 | 0.16x | CN¥409.61 Million | CN¥2.58 Billion | CN¥2.17 Billion | ▲ +78.1% |
| 2016 | 0.09x | CN¥188.08 Million | CN¥2.11 Billion | CN¥1.92 Billion | ▼ -62.5% |
| 2015 | 0.24x | CN¥385.49 Million | CN¥1.62 Billion | CN¥1.24 Billion | ▲ +253.3% |
| 2014 | 0.07x | CN¥80.78 Million | CN¥1.20 Billion | CN¥1.12 Billion | ▲ +339.6% |
| 2013 | -0.03x | CN¥-28.42 Million | CN¥1.01 Billion | CN¥1.04 Billion | ▲ +96.2% |
| 2012 | -0.74x | CN¥-495.08 Million | CN¥665.52 Million | CN¥1.16 Billion | ▲ +50.9% |
| 2011 | -1.52x | CN¥-480.18 Million | CN¥316.65 Million | CN¥796.83 Million | ▼ -127.1% |
| 2010 | -0.67x | CN¥-135.81 Million | CN¥203.36 Million | CN¥339.17 Million | ▼ -102.9% |
| 2009 | -0.33x | CN¥-86.20 Million | CN¥261.87 Million | CN¥348.07 Million | ▼ -442.3% |
| 2008 | 0.10x | CN¥22.41 Million | CN¥233.04 Million | CN¥210.63 Million | ▲ +116.2% |
| 2007 | -0.59x | CN¥-78.23 Million | CN¥131.48 Million | CN¥209.71 Million | ▼ -34.7% |
| 2006 | -0.44x | CN¥-81.69 Million | CN¥184.91 Million | CN¥266.61 Million | ▼ -142.9% |
| 2005 | -0.18x | CN¥-34.26 Million | CN¥188.35 Million | CN¥222.60 Million | ▼ -43884.5% |
| 2004 | 0.00x | CN¥85.20K | CN¥205.10 Million | CN¥205.02 Million | ▲ +100.1% |
| 2003 | -0.76x | CN¥-113.92 Million | CN¥150.14 Million | CN¥264.05 Million | ▼ -109.9% |
| 2002 | -0.36x | CN¥-37.05 Million | CN¥102.47 Million | CN¥139.52 Million | ▲ +66.4% |
| 2001 | -1.08x | CN¥-73.35 Million | CN¥68.15 Million | CN¥141.51 Million | ▼ -1362.5% |
| 2000 | 0.09x | CN¥11.80 Million | CN¥138.43 Million | CN¥126.63 Million | ▲ +108.2% |
| 1999 | -1.04x | CN¥-39.79 Million | CN¥38.20 Million | CN¥77.99 Million | ▼ -584.7% |
| 1998 | 0.21x | CN¥14.30 Million | CN¥66.55 Million | CN¥52.25 Million | — |